Ardsley Advisory Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-100,150
| Closed | -$9.72M | – | 159 |
|
|
2021
Q2 | $9.72M | Sell |
100,150
-35,400
| -26% | -$3.44M | 1.14% | 20 |
|
|
2021
Q1 | $9.27M | Sell |
135,550
-41,450
| -23% | -$2.83M | 1.13% | 21 |
|
|
2020
Q4 | $15.2M | Sell |
177,000
-80,000
| -31% | -$6.86M | 2.49% | 10 |
|
|
2020
Q3 | $16.7M | Sell |
257,000
-44,900
| -15% | -$2.92M | 3.22% | 5 |
|
|
2020
Q2 | $22.1M | Sell |
301,900
-69,350
| -19% | -$5.07M | 4.7% | 5 |
|
|
2020
Q1 | $12.6M | Sell |
371,250
-143,250
| -28% | -$4.86M | 4.94% | 4 |
|
|
2019
Q4 | $28M | Sell |
514,500
-149,950
| -23% | -$8.17M | 4.47% | 3 |
|
|
2019
Q3 | $27.7M | Buy |
664,450
+403,950
| +155% | +$16.8M | 6.21% | 2 |
|
|
2019
Q2 | $11.4M | Buy |
260,500
+250,500
| +2,505% | +$11M | 1.8% | 16 |
|
|
2019
Q1 | $515K | Buy |
+10,000
| New | +$515K | 0.1% | 70 |
|
|
2018
Q3 | – | Sell |
-10,000
| Closed | -$395K | – | 191 |
|
|
2018
Q2 | $395K | Buy |
+10,000
| New | +$395K | 0.06% | 108 |
|